Annual CFO:
-$230.11M-$84.74M(-58.29%)Summary
- As of today, AKRO annual cash from operations is -$230.11 million, with the most recent change of -$84.74 million (-58.29%) on December 31, 2024.
- During the last 3 years, AKRO annual cash from operations has fallen by -$150.43 million (-188.79%).
- AKRO annual cash from operations is now -5151.19% below its all-time high of -$4.38 million, reached on December 31, 2017.
Performance
AKRO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$48.25M+$19.42M(+28.70%)Summary
- As of today, AKRO quarterly cash from operations is -$48.25 million, with the most recent change of +$19.42 million (+28.70%) on June 30, 2025.
- Over the past year, AKRO quarterly cash from operations has increased by +$9.21 million (+16.03%).
- AKRO quarterly cash from operations is now -19121.51% below its all-time high of -$251.00 thousand, reached on June 30, 2018.
Performance
AKRO Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$253.42M+$9.21M(+3.51%)Summary
- As of today, AKRO TTM cash from operations is -$253.42 million, with the most recent change of +$9.21 million (+3.51%) on June 30, 2025.
- Over the past year, AKRO TTM cash from operations has dropped by -$62.48 million (-32.73%).
- AKRO TTM cash from operations is now -74877.51% below its all-time high of -$338.00 thousand, reached on March 31, 2018.
Performance
AKRO TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AKRO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -58.3% | +16.0% | -32.7% |
| 3Y3 Years | -188.8% | -147.3% | -202.8% |
| 5Y5 Years | -545.9% | -113.6% | -329.1% |
AKRO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -188.8% | at low | -115.5% | +31.5% | -173.9% | +3.5% |
| 5Y | 5-Year | -545.9% | at low | -257.2% | +31.5% | -329.1% | +3.5% |
| All-Time | All-Time | -5151.2% | at low | >-9999.0% | +31.5% | >-9999.0% | +3.5% |
AKRO Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$48.25M(+28.7%) | -$253.42M(+3.5%) |
| Mar 2025 | - | -$67.66M(-0.9%) | -$262.63M(-14.1%) |
| Dec 2024 | -$230.11M(-58.3%) | -$67.09M(+4.7%) | -$230.11M(-8.7%) |
| Sep 2024 | - | -$70.42M(-22.6%) | -$211.64M(-10.8%) |
| Jun 2024 | - | -$57.45M(-63.5%) | -$190.94M(-22.5%) |
| Mar 2024 | - | -$35.14M(+27.7%) | -$155.88M(-7.2%) |
| Dec 2023 | -$145.37M(-57.1%) | -$48.63M(+2.2%) | -$145.37M(-18.9%) |
| Sep 2023 | - | -$49.72M(-122.1%) | -$122.25M(-25.8%) |
| Jun 2023 | - | -$22.39M(+9.1%) | -$97.15M(-3.1%) |
| Mar 2023 | - | -$24.63M(+3.4%) | -$94.27M(-1.9%) |
| Dec 2022 | -$92.52M(-16.1%) | -$25.51M(-3.6%) | -$92.52M(+1.3%) |
| Sep 2022 | - | -$24.62M(-26.2%) | -$93.70M(-12.0%) |
| Jun 2022 | - | -$19.51M(+14.7%) | -$83.69M(+0.6%) |
| Mar 2022 | - | -$22.88M(+14.3%) | -$84.21M(-5.7%) |
| Dec 2021 | -$79.68M | -$26.70M(-82.8%) | -$79.68M(-4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$14.61M(+27.1%) | -$76.38M(-1.5%) |
| Jun 2021 | - | -$20.03M(-9.2%) | -$75.28M(+3.3%) |
| Mar 2021 | - | -$18.35M(+21.6%) | -$77.83M(-9.9%) |
| Dec 2020 | -$70.80M(-98.7%) | -$23.39M(-73.2%) | -$70.80M(-19.9%) |
| Sep 2020 | - | -$13.51M(+40.2%) | -$59.06M(-0.5%) |
| Jun 2020 | - | -$22.58M(-99.6%) | -$58.76M(-41.6%) |
| Mar 2020 | - | -$11.32M(+2.9%) | -$41.50M(-16.5%) |
| Dec 2019 | -$35.63M(-670.3%) | -$11.65M(+11.8%) | -$35.63M(-36.7%) |
| Sep 2019 | - | -$13.21M(-148.3%) | -$26.05M(-76.0%) |
| Jun 2019 | - | -$5.32M(+2.2%) | -$14.80M(-52.1%) |
| Mar 2019 | - | -$5.44M(-162.4%) | -$9.73M(-110.4%) |
| Dec 2018 | -$4.63M(-5.5%) | -$2.08M(-5.8%) | -$4.63M(-81.4%) |
| Sep 2018 | - | -$1.96M(-681.3%) | -$2.55M(-332.9%) |
| Jun 2018 | - | -$251.00K(+25.7%) | -$589.00K(-74.3%) |
| Mar 2018 | - | -$338.00K | -$338.00K |
| Dec 2017 | -$4.38M | - | - |
FAQ
- What is Akero Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Akero Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Akero Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Akero Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of AKRO is -$230.11M
What is the all-time high annual cash from operations for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual cash from operations is -$4.38M
What is Akero Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, AKRO annual cash from operations has changed by -$84.74M (-58.29%)
What is Akero Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of AKRO is -$48.25M
What is the all-time high quarterly cash from operations for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly cash from operations is -$251.00K
What is Akero Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, AKRO quarterly cash from operations has changed by +$9.21M (+16.03%)
What is Akero Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of AKRO is -$253.42M
What is the all-time high TTM cash from operations for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high TTM cash from operations is -$338.00K
What is Akero Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, AKRO TTM cash from operations has changed by -$62.48M (-32.73%)